Register / Log In

Pharmacy News

Gilead receives approval for two HIV-1 cocktail drugs
FDA has approved two new HIV-1 cocktail drugs: elvitegravir (Vitekta, Gilead), an integrase inhibitor and cobicistat (Tybost, Gilead), a protease-inhibitor booster.
Interaction with pharmacist key to patient satisfaction: J.D. Power study
How often do patients reach out to pharmacists in brick-and-mortar stores? The answer may surprise you.
FDA approves tiotropium bromide mist for COPD
FDA approved tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim Pharmaceuticals) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) and to reduce exacerbations in patients with COPD.
FDA approves once-weekly GLP-1 receptor agonist for type 2 diabetes
FDA has approved dulaglutide (Trulicity, Eli Lilly) to treat type 2 diabetes mellitus. The drug is a once-weekly subcutaneous injection used to improve glycemic control and is indicated as an adjunct to diet and exercise in the management of type 2 diabetes in adults.
Pharmacy in Blue Ridge: Two generations of small-town pharmacy
Two fathers and their sons keep the ideals of small-town pharmacy practice alive for 65 years.
Buprenorphine tops list for pediatric poisoning requiring hospitalization
Researchers from the Centers for Disease Control and Prevention (CDC) and FDA undertook a study to determine the most commonly implicated active ingredients responsible for childhood poisonings that required emergency hospitalization in the hope of identifying prevention and intervention strategies. Buprenorphine and clonidine were the most common of 12 active ingredients that were found in 45.0% of these hospitalizations.
Home infusion bill would benefit seriously ill Medicare patients
Proposed legislation that would cover home-based infusion therapy for Medicare beneficiaries could save the healthcare system approximately $80 million over 10 years and provide access to life-saving care at patients’ homes. The potential savings is outlined in a report released in June by Avalere.
BMJ Study: CV benefits of statin use far exceed risks
A literature review going back 20 years found only a modest increase in patients' risk of developing statin-related conditions.
Serving Mingo Junction
He's not filling a niche, he's serving a need, says pharmacist Frank Vostatek, who can add "role model" to the rest of his job description.
New once-weekly treatment for type 2 DM
Albiglutide injection is the newest GLP-1 approved for once-weekly dosing in patients with type II diabetes, to be used in addition to diet and exercise.
120x160px_drtp0914_CV.jpg
 
Stay Connected